Buy Ferrlecit 12.5 mg/mL sodium ferric gluconate complex

Ferrlecit 12.5 mg/mL is an intravenous injection containing sodium ferric gluconate complex, used to treat iron deficiency anemia. This single-use vial is suitable for medical professionals to administer under controlled conditions.

Strength

12.5 mg/mL

Pack Size

10 VIAL, SINGLE-USE in 1 CARTON (0024-2794-10) / 5 mL in 1 VIAL, SINGLE-USE (0024-2794-01)

Manufacturer / TM Owner

sanofi-aventis U.S. LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Ferrlecit 12.5 mg/mL is primarily used to address iron deficiency anemia in patients who cannot tolerate or do not respond to oral iron supplements. This intravenous injection is often considered when oral iron therapy is ineffective or impractical. The medication works by replenishing iron stores in the body, which is essential for the production of red blood cells.

Side Effects

Common effects of Ferrlecit 12.5 mg/mL may include temporary discomfort at the injection site, such as redness or swelling. Some patients might experience flu-like symptoms, including fever, chills, or muscle aches. These effects are generally mild and transient, but any persistent or severe reactions should be reported to a healthcare provider.

Precautions & Warnings

Ferrlecit 12.5 mg/mL should be administered by a healthcare professional in a clinical setting. Patients with a history of allergic reactions to iron products or any components of the injection should avoid this medication. It is important to monitor for signs of allergic reactions during and after administration.

Avoid Interactions

Ferrlecit 12.5 mg/mL may interact with other medications, particularly those that affect iron metabolism or kidney function. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided as it may exacerbate certain side effects.

References

Frequently Asked Questions

Ferrlecit 12.5 mg/mL is used to treat iron deficiency anemia in patients who cannot tolerate or do not respond to oral iron supplements.

Ferrlecit 12.5 mg/mL is administered intravenously by a healthcare professional in a clinical setting.

Common side effects may include discomfort at the injection site, redness, swelling, fever, chills, or muscle aches.

Patients should inform their healthcare provider about all medications they are taking, as Ferrlecit 12.5 mg/mL may interact with other drugs.

Patients with a history of allergic reactions to iron products or any components of the injection should avoid Ferrlecit 12.5 mg/mL.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.